Authorities claim that reddy divulged confidential information regarding a regulatory drug approval, the financial performance of his firm, and a proposed merger with a Pfizer division. According to an indictment, reddy allegedly used Dayakar Mallu as a conduit for information when he worked at Mylan NV, which just so happens to be a precursor business of Viatris.
In order to avoid being caught, Mallu paid reddy in indian rupees and from within India. reddy entered a not guilty plea in federal court in Pittsburg and provided a $500k unsecured bond. Mallu admitted admission to conspiracy and preparing fraudulent tax returns last year. reddy is allegedly on leave of absence, notwithstanding Viatris' substantial cooperation with the authorities' inquiries. watch out this space for more updates.